New eye surgery tech aims to prevent pressure spikes during cataract operations

NCT ID NCT07062107

Ongoing Symptom relief Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new adaptive fluidics system to traditional methods during cataract surgery. The goal is to keep eye pressure stable and reduce risks. About 320 adults with lens diseases will take part. The new system adjusts fluid flow in real time to avoid sudden pressure increases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: adaptive fluidics technology (a device that controls fluid pressure and flow during eye surgery)
What this could lead to: If successful, this technology could make cataract and other lens surgeries safer by reducing pressure spikes and complications.
What could go wrong: This is a relatively small, early-stage study comparing two surgical techniques. The new technology may not show significant benefits over the standard approach, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract lens disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LENS DISEASES

Contacts and locations

Locations

Second Affiliated Hospital, Zhejiang University School of Medicine,

Hangzhou, Zhejiang, 310009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.